Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-18 19:16 | 2023-10-16 | NRGX | PIMCO Dynamic Income Strategy Fund | Saba Capital Management, L.P. | 10% owner | Other | BUY | $19.29 | 119,930 | $2,313,797 | 7,029,711 | +1.7% |
| 2023-10-18 17:53 | 2023-10-16 | EMO | ClearBridge Energy Midstream Opportunity Fund Inc. | Saba Capital Management, L.P. | 10% owner | Other | BUY | $32.51 | 32,388 | $1,052,976 | 2,636,531 | +1.2% |
| 2023-10-18 17:49 | 2023-10-16 | ECAT | BlackRock ESG Capital Allocation Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $14.76 | 523,185 | $7,723,832 | 16,889,644 | +3.2% |
| 2023-10-18 17:47 | 2023-10-16 | BIGZ | BlackRock Technology & Private Equity Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $6.93 | 1,375,704 | $9,535,692 | 28,001,581 | +5.2% |
| 2023-10-18 23:19 | 2023-10-16 | ASAN | Asana Inc. | Moskovitz Dustin A. | Director, Officer, 10% owner - President, CEO, & Chair | Services-Prepackaged Software | BUY | $18.67 | 280,000 | $5,226,676 | 47,537,874 | +0.6% |
| 2023-10-18 23:30 | 2023-10-16 | CERE | N/A | Gordon Christopher R | Director, 10% owner | Other | BUY | $22.81 | 5,480,052 | $124,999,986 | 65,679,781 | +9.1% |
| 2023-10-19 00:46 | 2023-10-16 | SRRK | Scholar Rock Holding Corp | AKKARAJU SRINIVAS | Director, 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $6.85 | 2,189,781 | $15,000,000 | 6,788,609 | +47.6% |
| 2023-10-18 19:08 | 2023-10-16 | MHI | N/A | Saba Capital Management, L.P. | 10% owner | Other | BUY | $7.27 | 245,080 | $1,780,727 | 2,672,608 | +10.1% |
| 2023-10-18 23:11 | 2023-10-16 | ATXS | Astria Therapeutics, Inc. | PERCEPTIVE ADVISORS LLC | Director | Pharmaceutical Preparations | BUY | $6.51 | 1,074,608 | $6,999,997 | 1,611,699 | +200.1% |
| 2023-10-18 23:30 | 2023-10-16 | CERE | N/A | BAIN CAPITAL INVESTORS LLC | 10% owner | Other | BUY | $22.81 | 5,480,052 | $124,999,986 | 65,679,781 | +9.1% |
| 2023-10-17 23:53 | 2023-10-16 | CERE | N/A | PERCEPTIVE ADVISORS LLC | Director | Other | BUY | $22.81 | 876,808 | $19,999,990 | 10,794,876 | +8.8% |
| 2023-10-18 02:41 | 2023-10-13 | TNGX | Tango Therapeutics, Inc. | Boxer Capital, LLC | Other | Pharmaceutical Preparations | BUY | $6.98 | 1,250,000 | $8,722,500 | 8,198,642 | +18.0% |
| 2023-10-16 23:18 | 2023-10-12 | CCLFX | N/A | Nesbitt Stephen Lane | Officer, 10% owner - President | Other | BUY | $10.54 | 5,692,600 | $60,000,000 | 5,828,711 | +4,182.3% |
| 2023-10-16 23:06 | 2023-10-13 | SMMT | Summit Therapeutics Inc. | Soni Manmeet Singh | Director, Officer - Chief Operating Officer | Pharmaceutical Preparations | BUY | $1.68 | 2,976,190 | $4,999,999 | 2,976,190 | +100.0% |
| 2023-10-16 15:31 | 2023-10-12 | ECAT | BlackRock ESG Capital Allocation Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $14.90 | 268,450 | $3,998,965 | 16,366,459 | +1.7% |
| 2023-10-16 15:23 | 2023-10-12 | BIGZ | BlackRock Technology & Private Equity Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $6.96 | 378,236 | $2,631,842 | 26,625,877 | +1.4% |
| 2023-10-17 00:44 | 2023-10-12 | ASAN | Asana Inc. | Moskovitz Dustin A. | Director, Officer, 10% owner - President, CEO, & Chair | Services-Prepackaged Software | BUY | $17.96 | 347,802 | $6,244,994 | 47,257,874 | +0.7% |
| 2023-10-17 00:27 | 2023-10-12 | HHH | Howard Hughes Holdings Inc. | Pershing Square Capital Management, L.P. | Director, 10% owner | Real Estate Investment Trusts | BUY | $68.33 | 116,536 | $7,963,115 | 17,217,007 | +0.7% |
| 2023-10-17 00:46 | 2023-10-12 | SRRK | Scholar Rock Holding Corp | Invus Public Equities, L.P. | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $6.86 | 2,199,931 | $15,086,687 | 11,259,438 | +24.3% |
| 2023-10-13 23:42 | 2023-10-11 | QETAU | Quetta Acquisition Corp | Yocto Investments LLC | 10% owner | Blank Checks | BUY | $10.00 | 253,045 | $2,530,450 | 1,970,045 | +14.7% |
| 2023-10-13 23:43 | 2023-10-11 | QETAU | Quetta Acquisition Corp | Chen Hui | Director, Officer, 10% owner - CEO and Chairman | Blank Checks | BUY | $10.00 | 253,045 | $2,530,450 | 1,970,045 | +14.7% |
| 2023-10-12 21:32 | 2023-10-10 | ECAT | BlackRock ESG Capital Allocation Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $14.82 | 181,264 | $2,686,604 | 16,098,009 | +1.1% |
| 2023-10-12 21:17 | 2023-10-10 | BIGZ | BlackRock Technology & Private Equity Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $7.10 | 1,080,978 | $7,673,214 | 26,016,611 | +4.3% |
| 2023-10-12 23:25 | 2023-10-10 | ASAN | Asana Inc. | Moskovitz Dustin A. | Director, Officer, 10% owner - President, CEO, & Chair | Services-Prepackaged Software | BUY | $18.07 | 283,204 | $5,116,902 | 46,910,072 | +0.6% |
| 2023-10-12 23:01 | 2023-10-10 | LXRX | LEXICON PHARMACEUTICALS, INC. | DEBBANE RAYMOND | Director | Pharmaceutical Preparations | BUY | $1.10 | 1,000,000 | $1,104,000 | 1,340,847 | +293.4% |
| 2023-10-12 18:35 | 2023-10-10 | CUK | CARNIVAL PLC | WEISENBURGER RANDALL J | Director | Water Transportation | BUY | $12.99 | 350,000 | $4,544,785 | 961,238 | +57.3% |
| 2023-10-12 18:34 | 2023-10-10 | CCL | CARNIVAL CORP | WEISENBURGER RANDALL J | Director | Water Transportation | BUY | $12.99 | 350,000 | $4,544,785 | 961,238 | +57.3% |
| 2023-10-12 03:52 | 2023-10-11 | N/A | Morgan Stanley Direct Lending Fund | MS Credit Partners Holdings Inc. | 10% owner | Other | BUY | $20.62 | 1,313,018 | $27,074,438 | 9,727,311 | +15.6% |
| 2023-10-11 23:20 | 2023-10-06 | N/A | N/A | FEPCF Founders Fund, L.P. | 10% owner | Other | BUY | $24.23 | 5,213,274 | $126,299,910 | 6,265,274 | +495.6% |
| 2023-10-11 23:53 | 2023-10-09 | HHH | Howard Hughes Holdings Inc. | Pershing Square Capital Management, L.P. | Director, 10% owner | Real Estate Investment Trusts | BUY | $69.29 | 93,390 | $6,470,946 | 17,100,471 | +0.5% |
| 2023-10-10 23:07 | 2023-10-06 | N/A | N/A | NEXTERA ENERGY INC | 10% owner | Other | BUY | $24.21 | 3,097,524 | $75,000,039 | 4,097,524 | +309.8% |
| 2023-10-11 04:18 | 2023-10-06 | FNKO | Funko, Inc. | Working Capital Advisors (UK) Ltd. | 10% owner | Games, Toys & Children's Vehicles (No Dolls & Bicycles) | BUY | $6.84 | 225,782 | $1,543,559 | 7,092,677 | +3.3% |
| 2023-10-10 14:17 | 2023-10-05 | BHVN | Biohaven Ltd. | Coric Vlad | Director, Officer - Chief Executive Officer | Pharmaceutical Preparations | BUY | $22.00 | 454,545 | $9,999,990 | 1,657,031 | +37.8% |
| 2023-10-10 23:00 | 2023-10-05 | MLTX | MoonLake Immunotherapeutics | Chen Bihua | 10% owner | Pharmaceutical Preparations | BUY | $59.90 | 58,839 | $3,524,297 | 8,494,151 | +0.7% |
| 2023-10-10 23:09 | 2023-10-06 | VOXX | N/A | Downing Steven R | Director | Other | BUY | $10.00 | 1,570,000 | $15,700,000 | 1,743,808 | +903.3% |
| 2023-10-11 01:59 | 2023-10-06 | ECAT | BlackRock ESG Capital Allocation Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $14.74 | 175,863 | $2,591,464 | 15,916,745 | +1.1% |
| 2023-10-10 21:53 | 2023-10-06 | BIGZ | BlackRock Technology & Private Equity Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $6.92 | 740,443 | $5,120,460 | 24,935,633 | +3.1% |
| 2023-10-11 04:48 | 2023-09-29 | CELU | Celularity Inc | Hariri Robert J | Director, Officer - Chief Executive Officer | Pharmaceutical Preparations | BUY | $0.16 | 18,422,124 | $2,984,384 | 28,570,434 | +181.5% |
| 2023-10-10 15:00 | 2023-10-05 | ERAS | Erasca, Inc. | Lim Jonathan E | Director, Officer, 10% owner - Chairman & CEO | Pharmaceutical Preparations | BUY | $2.03 | 1,000,000 | $2,026,000 | 19,456,216 | +5.4% |
| 2023-10-11 02:07 | 2023-10-05 | BHVN | Biohaven Ltd. | CHILDS JOHN W | Director | Pharmaceutical Preparations | BUY | $22.00 | 454,545 | $9,999,990 | 2,111,663 | +27.4% |
| 2023-10-07 00:54 | 2023-10-04 | ECAT | BlackRock ESG Capital Allocation Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $14.53 | 300,344 | $4,364,899 | 15,740,882 | +1.9% |
| 2023-10-07 00:49 | 2023-10-04 | BIGZ | BlackRock Technology & Private Equity Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $6.80 | 568,679 | $3,868,837 | 24,195,190 | +2.4% |
| 2023-10-07 02:43 | 2023-10-04 | STAA | STAAR SURGICAL CO | BROADWOOD PARTNERS, L.P. | 10% owner | Ophthalmic Goods | BUY | $37.81 | 205,296 | $7,762,468 | 9,469,723 | +2.2% |
| 2023-10-06 23:33 | 2023-10-04 | HHH | Howard Hughes Holdings Inc. | Pershing Square Capital Management, L.P. | Director, 10% owner | Real Estate Investment Trusts | BUY | $69.74 | 117,773 | $8,213,736 | 17,007,081 | +0.7% |
| 2023-10-05 23:23 | 2023-10-03 | ASAN | Asana Inc. | Moskovitz Dustin A. | Director, Officer, 10% owner - President, CEO, & Chair | Services-Prepackaged Software | BUY | $17.53 | 1,015,000 | $17,792,950 | 46,626,868 | +2.2% |
| 2023-10-05 23:30 | 2023-10-03 | VCNX | VACCINEX, INC. | FRIEDBERG ALBERT | Director, 10% owner | Pharmaceutical Preparations | BUY | $1.00 | 3,000,000 | $3,000,000 | 4,747,794 | +171.6% |
| 2023-10-05 00:15 | 2023-10-02 | IMVT | Immunovant, Inc. | Roivant Sciences Ltd. | Director, 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $38.00 | 1,526,316 | $58,000,008 | 79,805,331 | +1.9% |
| 2023-10-05 00:52 | 2023-10-02 | MLTX | MoonLake Immunotherapeutics | Chen Bihua | 10% owner | Pharmaceutical Preparations | BUY | $57.30 | 293,212 | $16,800,344 | 8,435,312 | +3.6% |
| 2023-10-05 01:23 | 2023-10-02 | RMAX | RE/MAX Holdings, Inc. | Peterson Adam K | 10% owner | Real Estate Agents & Managers (For Others) | BUY | $12.49 | 215,565 | $2,692,084 | 2,840,672 | +8.2% |
| 2023-10-05 00:00 | 2023-10-02 | N-A | N/A | Invesco Realty, Inc. | 10% owner | Other | BUY | $25.12 | 796,323 | $19,999,980 | 1,052,487 | +310.9% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.